{"id":"albuterol-inhalation-aerosol","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Tremors"},{"rate":"10-20%","effect":"Nervousness"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Palpitations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by binding to beta-2 adrenergic receptors on bronchial smooth muscle cells, causing them to relax and decrease airway resistance. This results in improved lung function and relief of bronchospasm symptoms.","oneSentence":"Albuterol inhalation aerosol is a beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:00:35.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Maintenance and relief of bronchospasm in patients with asthma and in patients with COPD"}]},"trialDetails":[{"nctId":"NCT06676319","phase":"PHASE2","title":"Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-11-07","conditions":"Asthma","enrollment":1147},{"nctId":"NCT06471257","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-17","conditions":"Asthma","enrollment":790},{"nctId":"NCT06307665","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-20","conditions":"Asthma","enrollment":440},{"nctId":"NCT01931696","phase":"NA","title":"Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-08","conditions":"Asthma","enrollment":200},{"nctId":"NCT06422689","phase":"PHASE4","title":"Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-10","conditions":"Asthma","enrollment":1507},{"nctId":"NCT06876064","phase":"","title":"National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2025-10","conditions":"Rheumatoid Arthritis (RA)","enrollment":150},{"nctId":"NCT06245551","phase":"PHASE3","title":"A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-12-22","conditions":"Asthma, Exercise-Induced","enrollment":64},{"nctId":"NCT06154304","phase":"PHASE3","title":"BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2023-12-06","conditions":"Bronchial Asthma","enrollment":120},{"nctId":"NCT05987371","phase":"PHASE2","title":"A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-08-23","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":75},{"nctId":"NCT04912596","phase":"NA","title":"Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma","status":"RECRUITING","sponsor":"Intech Biopharm Ltd.","startDate":"2022-08-15","conditions":"Mild Asthma","enrollment":148},{"nctId":"NCT06816342","phase":"PHASE4","title":"Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2024-11-01","conditions":"Asthmatic Patients, MDI, Aerosol Generating Procedure","enrollment":120},{"nctId":"NCT06815679","phase":"PHASE2, PHASE3","title":"Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC","status":"NOT_YET_RECRUITING","sponsor":"Università degli Studi di Ferrara","startDate":"2025-03-01","conditions":"Acute Respiratory Failure, Pneumonia","enrollment":20},{"nctId":"NCT06618105","phase":"PHASE3","title":"Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd","status":"NOT_YET_RECRUITING","sponsor":"Macleods Pharmaceuticals Ltd","startDate":"2024-10-15","conditions":"Mild Asthma","enrollment":144},{"nctId":"NCT06157515","phase":"NA","title":"Inhaled Dose Analysis Using a Breath Actuated Nebulizer in Healthy Subjects","status":"COMPLETED","sponsor":"Chang Gung University","startDate":"2024-03-13","conditions":"Healthy Volunteers, Aerosol Therapy, Inhaled Drug Dose","enrollment":25},{"nctId":"NCT03199976","phase":"PHASE4","title":"Efficacy of Intermittent Tiotropium in Early Childhood Wheezing","status":"TERMINATED","sponsor":"Helsinki University Central Hospital","startDate":"2016-04-20","conditions":"Wheezy Bronchitis, Asthmatic Bronchitis, Wheezing","enrollment":80},{"nctId":"NCT04803734","phase":"NA","title":"Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2021-03-19","conditions":"Healthy","enrollment":60},{"nctId":"NCT05300087","phase":"NA","title":"Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2022-02-24","conditions":"Healthy","enrollment":60},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT05602259","phase":"NA","title":"PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2022-10-27","conditions":"Non-small Cell Lung Cancer","enrollment":200},{"nctId":"NCT02889809","phase":"PHASE4","title":"Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Asthma","enrollment":477},{"nctId":"NCT00388882","phase":"PHASE4","title":"Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-10-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":327},{"nctId":"NCT00274560","phase":"PHASE3","title":"A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-05-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":653},{"nctId":"NCT03181152","phase":"","title":"The Application of Impulse Oscillometry on the Diagnosis of ACOS,Asthma and COPD.","status":"UNKNOWN","sponsor":"Shengjing Hospital","startDate":"2017-06-10","conditions":"Asthma-COPD Overlap Syndrome, Asthma, COPD","enrollment":100},{"nctId":"NCT06040424","phase":"PHASE3","title":"Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"UNKNOWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2023-09-28","conditions":"COPD","enrollment":74},{"nctId":"NCT03029156","phase":"NA","title":"Effectiveness of the Aeroneb in Acute Severe Asthma","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2015-08","conditions":"Asthma Exacerbation","enrollment":31},{"nctId":"NCT04606394","phase":"PHASE4","title":"Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD","status":"COMPLETED","sponsor":"Pulmonary Research Institute of Southeast Michigan","startDate":"2020-12-02","conditions":"COPD","enrollment":30},{"nctId":"NCT03847896","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2019-03-20","conditions":"Asthma","enrollment":1001},{"nctId":"NCT04655170","phase":"PHASE4","title":"Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD","status":"UNKNOWN","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2020-12-09","conditions":"COPD Exacerbation","enrollment":60},{"nctId":"NCT03842839","phase":"NA","title":"Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2018-10-01","conditions":"Airway Remodeling","enrollment":100},{"nctId":"NCT03769090","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2018-12-13","conditions":"Asthma","enrollment":3132},{"nctId":"NCT00530062","phase":"PHASE4","title":"Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-07-25","conditions":"Asthma","enrollment":49},{"nctId":"NCT03387852","phase":"PHASE2","title":"Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-03-12","conditions":"Asthma","enrollment":296},{"nctId":"NCT05292976","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation","status":"WITHDRAWN","sponsor":"Aurobindo Pharma Ltd","startDate":"2022-04","conditions":"Bronchial Asthma","enrollment":""},{"nctId":"NCT02573233","phase":"PHASE2","title":"Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-01-27","conditions":"Asthma","enrollment":42},{"nctId":"NCT00308685","phase":"PHASE3","title":"Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2006-06-10","conditions":"Asthma","enrollment":95},{"nctId":"NCT02948959","phase":"PHASE3","title":"Evaluation of Dupilumab in Children With Uncontrolled Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-04-21","conditions":"Asthma","enrollment":408},{"nctId":"NCT04681079","phase":"","title":"Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2021-05-04","conditions":"COVID-19","enrollment":14},{"nctId":"NCT01899144","phase":"PHASE2","title":"Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-07","conditions":"Asthma","enrollment":61},{"nctId":"NCT04234464","phase":"PHASE3","title":"A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2020-01-15","conditions":"Exercise Induced Bronchospasm","enrollment":60},{"nctId":"NCT02139644","phase":"PHASE3","title":"Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-06","conditions":"Asthma","enrollment":787},{"nctId":"NCT00577655","phase":"PHASE3","title":"Albuterol HFA MDI in Pediatric Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-08","conditions":"Asthma","enrollment":103},{"nctId":"NCT01058863","phase":"PHASE2","title":"A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-02","conditions":"Asthma","enrollment":72},{"nctId":"NCT02513160","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-09-30","conditions":"Persistent Asthma","enrollment":713},{"nctId":"NCT03468790","phase":"PHASE3","title":"Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.","status":"COMPLETED","sponsor":"Shanghai Biomabs Pharmaceutical Co., Ltd.","startDate":"2018-05-09","conditions":"Asthma, Allergic","enrollment":393},{"nctId":"NCT04446637","phase":"PHASE3","title":"Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD","status":"WITHDRAWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2021-09-03","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":""},{"nctId":"NCT03528577","phase":"PHASE3","title":"A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2018-09-22","conditions":"Asthma","enrollment":128},{"nctId":"NCT02584257","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Lupin, Inc.","startDate":"2016-04","conditions":"Mild Persistent Asthma","enrollment":217},{"nctId":"NCT00388739","phase":"NA","title":"Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2006-11-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT02483975","phase":"PHASE3","title":"Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-09","conditions":"Asthma","enrollment":111},{"nctId":"NCT03934333","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-05-16","conditions":"Relative Bioavailability","enrollment":11},{"nctId":"NCT02624505","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2015-12","conditions":"Bronchial Asthma","enrollment":110},{"nctId":"NCT02794480","phase":"PHASE4","title":"Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-08-22","conditions":"Asthma","enrollment":324},{"nctId":"NCT02172794","phase":"PHASE3","title":"Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":48},{"nctId":"NCT02182674","phase":"PHASE2","title":"A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":66},{"nctId":"NCT00565266","phase":"PHASE3","title":"Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2008-05","conditions":"Asthma","enrollment":210},{"nctId":"NCT00394329","phase":"PHASE3","title":"(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2006-11","conditions":"Asthma","enrollment":288},{"nctId":"NCT03549897","phase":"PHASE3","title":"Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base","status":"UNKNOWN","sponsor":"Amneal Ireland Limited","startDate":"2018-03-16","conditions":"Asthma","enrollment":100},{"nctId":"NCT00706446","phase":"NA","title":"The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2008-06","conditions":"Asthma","enrollment":255},{"nctId":"NCT03169504","phase":"PHASE3","title":"Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2017-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":150},{"nctId":"NCT01174732","phase":"PHASE2","title":"Dose-Ranging Study of A006 DPI, in Adult Asthma Patients","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2010-07","conditions":"Asthma, Bronchospasm","enrollment":26},{"nctId":"NCT00901368","phase":"PHASE4","title":"FACTO Study (Foster® As Complete Treatment Option)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-05","conditions":"Asthmatic Patients","enrollment":431},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT00434993","phase":"PHASE2, PHASE3","title":"Drug Study of Albuterol to Treat Acute Lung Injury","status":"TERMINATED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-08","conditions":"Respiratory Distress Syndrome, Adult","enrollment":282},{"nctId":"NCT02764307","phase":"NA","title":"Aerosol Delivery in Different Types of Nebulizers","status":"COMPLETED","sponsor":"Chang Gung University","startDate":"2015-10","conditions":"Asthma","enrollment":10},{"nctId":"NCT02818270","phase":"NA","title":"Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation","status":"COMPLETED","sponsor":"Chang Gung University","startDate":"2016-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":30},{"nctId":"NCT01495442","phase":"NA","title":"Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-12","conditions":"Adult Healthy Volunteers","enrollment":6},{"nctId":"NCT02343419","phase":"NA","title":"Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Methacholine Challenge Test","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2014-11","conditions":"Bronchial Hyperreactivity, Abnormal Respiratory Airway Resistance","enrollment":46},{"nctId":"NCT00144846","phase":"PHASE3","title":"Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-09","conditions":"Asthma","enrollment":80},{"nctId":"NCT02150499","phase":"PHASE3","title":"A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects","status":"TERMINATED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2014-07","conditions":"Asthma","enrollment":18},{"nctId":"NCT02592122","phase":"NA","title":"Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"snow","startDate":"2013-10","conditions":"Lung Disease,Obstructive","enrollment":120},{"nctId":"NCT01457261","phase":"PHASE1","title":"IPF Drug Deposition Study","status":"COMPLETED","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2012-04","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":10},{"nctId":"NCT02247856","phase":"NA","title":"COPD AND ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION","status":"COMPLETED","sponsor":"Daniella Cunha Brandao","startDate":"2013-01","conditions":"COPD","enrollment":9},{"nctId":"NCT00809757","phase":"PHASE3","title":"A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2008-12","conditions":"Asthma","enrollment":197},{"nctId":"NCT02182700","phase":"PHASE3","title":"Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"1998-07","conditions":"Asthma","enrollment":47},{"nctId":"NCT02177253","phase":"PHASE3","title":"Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1118},{"nctId":"NCT02172287","phase":"PHASE3","title":"Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-02","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":623},{"nctId":"NCT00359788","phase":"PHASE4","title":"A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":349},{"nctId":"NCT00239499","phase":"PHASE4","title":"Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-09","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":107},{"nctId":"NCT00274534","phase":"PHASE3","title":"A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-12","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":36},{"nctId":"NCT00634517","phase":"PHASE3","title":"4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2008-03","conditions":"Asthma","enrollment":48},{"nctId":"NCT00634829","phase":"PHASE3","title":"Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2008-02","conditions":"Asthma, Bronchospasm","enrollment":24},{"nctId":"NCT01823926","phase":"NA","title":"Asthma and Quantifying Delivery Of Radio Labeled Aerosol","status":"COMPLETED","sponsor":"Universidade Federal de Pernambuco","startDate":"2011-10","conditions":"Asthma","enrollment":13},{"nctId":"NCT00545272","phase":"PHASE2","title":"A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-10","conditions":"Asthma","enrollment":392},{"nctId":"NCT00557466","phase":"PHASE2","title":"A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-10","conditions":"COPD","enrollment":568},{"nctId":"NCT00073840","phase":"PHASE3","title":"Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2002-12","conditions":"Asthma","enrollment":386},{"nctId":"NCT00981851","phase":"NA","title":"Interaction in Chronic Obstructive Pulmonary Disease Experiment","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2009-09","conditions":"Chronic Obstructive Pulmonary Disease, Cardiovascular Disease, Smoking","enrollment":40},{"nctId":"NCT00385359","phase":"PHASE4","title":"A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2006-10","conditions":"Asthma","enrollment":10},{"nctId":"NCT00325767","phase":"PHASE4","title":"Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2004-05","conditions":"Mucociliary Clearance","enrollment":10}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"PHARMACEUTICAL PRODUCT COMPLAINT"},{"count":1,"reaction":"ALOPECIA"},{"count":1,"reaction":"ANGIOEDEMA"},{"count":1,"reaction":"DEVICE DEFECTIVE"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"HAIR COLOUR CHANGES"},{"count":1,"reaction":"HAIR DISORDER"},{"count":1,"reaction":"HAIR TEXTURE ABNORMAL"},{"count":1,"reaction":"MADAROSIS"}],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Proventil","Proventil-HFA"],"phase":"phase_3","status":"active","brandName":"albuterol inhalation aerosol","genericName":"albuterol inhalation aerosol","companyName":"Amphastar Pharmaceuticals, Inc.","companyId":"amphastar-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albuterol inhalation aerosol is a beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs. Used for Maintenance and relief of bronchospasm in patients with asthma and in patients with COPD.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}